BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23435567)

  • 1. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.
    L'Espérance S; Frenette S; Dionne A; Dionne JY;
    Support Care Cancer; 2013 May; 21(5):1461-74. PubMed ID: 23435567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions.
    Johns C; Seav SM; Dominick SA; Gorman JR; Li H; Natarajan L; Mao JJ; Irene Su H
    Breast Cancer Res Treat; 2016 Apr; 156(3):415-426. PubMed ID: 27015968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors.
    Wiśniewska I; Jochymek B; Lenart-Lipińska M; Chabowski M
    Breast Cancer; 2016 Mar; 23(2):178-82. PubMed ID: 26498637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Raccah-Tebeka B; Boutet G; Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):373-393. PubMed ID: 33757925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].
    Palácová M
    Klin Onkol; 2016; 29 Suppl 3():S29-38. PubMed ID: 28118722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhormonal alternatives for the treatment of hot flashes.
    Sicat BL; Brokaw DK
    Pharmacotherapy; 2004 Jan; 24(1):79-93. PubMed ID: 14740790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
    Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B
    Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
    Taleghani SY; Etesam F; Esfandbod M
    Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis.
    Hervik JB; Stub T
    Breast Cancer Res Treat; 2016 Nov; 160(2):223-236. PubMed ID: 27709351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
    Bordeleau L; Pritchard K; Goodwin P; Loprinzi C
    Clin Ther; 2007 Feb; 29(2):230-41. PubMed ID: 17472816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hot flashes in breast cancer survivors and men with prostate cancer.
    Stearns V
    Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
    Jacobson JS; Troxel AB; Evans J; Klaus L; Vahdat L; Kinne D; Lo KM; Moore A; Rosenman PJ; Kaufman EL; Neugut AI; Grann VR
    J Clin Oncol; 2001 May; 19(10):2739-45. PubMed ID: 11352967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms and treatment in cancer therapy-induced early menopause.
    Boekhout AH; Beijnen JH; Schellens JH
    Oncologist; 2006 Jun; 11(6):641-54. PubMed ID: 16794243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
    Toulis KA; Tzellos T; Kouvelas D; Goulis DG
    Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.
    Hutton B; Yazdi F; Bordeleau L; Morgan S; Cameron C; Kanji S; Fergusson D; Tricco A; Straus S; Skidmore B; Hersi M; Pratt M; Mazzarello S; Brouwers M; Moher D; Clemons M
    Syst Rev; 2015 Aug; 4():114. PubMed ID: 26307105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
    Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
    J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
    Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
    Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hot flashes in palliative care. Part 2 #262.
    Lefkowits CC; Arnold RM
    J Palliat Med; 2013 Jan; 16(1):101-2. PubMed ID: 23317326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.